Antioxidants and pro-, pre- and synbiotics may be promising in the treatment of metabolic-associated fatty liver disease (MAFLD) but the benefits of fatty acids and vitamin D are less conclusive, according to a new review and meta-analysis.
A flavonoid compound found in hops could aid in tackling a common liver disease with researchers noting fewer negative side effects than current drugs as well as potential use in addressing metabolic syndrome.
Newly formed NovoBiome becomes the latest firm to delve into the gut microbiome as it aims to harness Artificial Intelligence (AI) to develop Live Biotherapeutic Products (LBPs) that address liver conditions.
A combination of Bergamot citrus and wild cardoon may reduce fat build-up in the livers of people with Non-alcoholic fatty liver (NAFL or steatosis), says a new study from the University Magna Grecia in Italy.
Supplementation with delta tocotrienol may improve liver health markers in people with Non-Alcoholic Fatty Liver Disease (NAFLD), says a new study that claims to be the first to the efficacy of this vitamin E form in this population.
The American Liver Foundation estimates at least 25% of the US population has nonalcoholic fatty liver disease, a condition in which excess fat is stored in your liver. NAFLD is the most common chronic liver condition and currently there are no approved...
FREE Liver Health Webinar on Feb. 28, 2019 @ 1 PM EST
Daily prebiotic and probiotic supplementation can decrease inflammation and increase antioxidant capacity in non-alcoholic fatty liver disease (NAFLD) patients, according to an Iranian population study.